Synthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase

scientific article published on 28 June 2010

Synthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/14756361003671060
P698PubMed publication ID20583855

P2093author name stringYing Yang
Lei Shi
Huan-Qiu Li
Hai-Liang Zhu
Suo-Ping Xu
Xiao-Ming Ruan
Zhen-Wei Zhu
P2860cites workAutomated docking of flexible ligands: applications of AutoDockQ28285420
A semiempirical free energy force field with charge-based desolvationQ29614316
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityQ30658242
Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterasesQ36942279
A cation-pi interaction in the binding site of the glycine receptor is mediated by a phenylalanine residueQ37112929
Prevalence of aberrant expression of the epidermal growth factor receptor in human cancersQ37220614
Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitorQ38569562
Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4-onesQ39988942
Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivativesQ40161879
The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR).Q40270624
New cytotoxic cyclic peptides and dianthramide from Dianthus superbus.Q40512018
Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorQ42557425
Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-triazene" BJ2000, a new probe for Combi-Targeting postulatesQ42810380
A specific inhibitor of the epidermal growth factor receptor tyrosine kinaseQ42834515
Diaminoindanes as microsomal triglyceride transfer protein inhibitorsQ43821275
Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitorsQ44618879
P433issue1
P921main subjecttribromsalanQ27219423
P304page(s)37-45
P577publication date2010-06-28
P1433published inJournal of Enzyme Inhibition and Medicinal ChemistryQ15708877
P1476titleSynthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase
P478volume26

Reverse relations

cites work (P2860)
Q58851373Antibacterial Activity of Salicylanilide 4-(Trifluoromethyl)-benzoates
Q28546591Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus
Q89883272Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
Q38982197Synthesis and evaluation of salicylanilide derivatives as potential epidermal growth factor receptor inhibitors

Search more.